Skip to main content
. 2021 Mar 1;12:616507. doi: 10.3389/fgene.2021.616507

Figure 2.

Figure 2

The mRNA expression-based stemness index (mRNAsi), corrected mRNAsi and clinical characteristics in glioma. (A) The expression level of mRNAsi in normal (five samples) and tumor (606 samples) tissues. (B) Expression level of mRNAsi in gliomas of different WHO grades. (C) Kaplan-Meier survival analysis of the relationship between mRNAsi and overall survival (OS). (D) The expression level of corrected mRNAsi (mRNAsi/tumor purity) in normal (five samples) and tumor (583 samples) tissues (23 samples cannot calculate the tumor purity). (E) The expression level of corrected mRNAsi in glioma of different WHO grades. (F) Kaplan-Meier survival analysis of the relationship between corrected mRNAsi and OS.